Management of Prostate Cancer (Current Clinical Urology)

Description

• Focuses on the full spectrum of disease from current molecular and genetic hypotheses regarding risk and progression
• Authors will represent a broad spectrum of opinion and expertise in the prostate cancer community
• Provide an updated, concise overview of major themes and controversies in the epidemiology, diagnosis, and management of prostate cancer

The thoroughly updated and revised third edition of Management of Prostate Cancer provides concise and authoritative guidance to today's best therapeutic regimens for the diagnosis and treatment of prostate cancer. Highlighting the latest major advances in the field, the book includes chapters on the most controversial areas of prostate cancer – screening, chemoprevention, and active surveillance; updated chapters on genetic risk and progression, biopsy schemes, treatment of complications, and comparative treatment outcomes for surgery; and new chapters on risk factors, new markers, nomograms, and focal therapy. This volume also features overviews of new and emerging drugs and treatment paradigms for castrate resistant disease, advances that promise to extend life and perhaps even cure a subset of men with metastatic disease.

With its comprehensive illustrations and contributions from renowned experts in the field, Management of Prostate Cancer, 3rd Edition is an invaluable resource for practitioners in the treatment of prostate cancer.

Table of contents

1 Epidemiology and Risk Factors
Ranko Miocinovic
2 Twenty years and counting: is PSA still useful in 2010?
Haluk Ozen
Sertac Yazici
3 Prostate Cancer Screening: A Review of the Evidence with Clinical Practice Implications
Timothy J Wilt
4 Beyond PSA: Promising New Markers for Prostate Cancer
Leonard Marks
5 Hereditary Prostate Cancer and Genetic Risk
Adam C Reese
Graham Casey
John S Witte
6 Prostate Inflammation and Prostate Cancer
William G. Nelson
Karen S. Sfanos
Angelo M. DeMarzo
Srinivasan Yegnasubramanian
7 Molecular Progression of Prostate Cancer: Androgens and Estrogens
Stephen A. Boorjian
Donald J Tindall
8 The Role of Obesity and Diet in Prostate Cancer
Jean-Alfred Thomas, II
Stephen J Freedland
9 Prostate Cancer Risk Reduction by Chemoprevention
Kenneth G. Nepple
Adam S. Kibel
Gerald L Andriole
10 Current Issues in Pathologic Evaluation
Sara M. Falzarano
Howard S. Levin
Cristina Magi-Galluzzi
11 Optimum Prostate Biopsy: Technique and Strategies
Osama M. Zaytoun
J. Stephen Jones
12 The Utility of Nomograms in Routine Clinical Practice
Carvell T. Nguyen
Michael W. Kattan
13 Active Surveillance Comes of Age
Laurence Klotz
14 Focal Therapy: Prostate Hemiablation as the First Historical Treatment Model for Focal Therapy of Early Stage Prostate Cancer
Vladimir Mouraviev
Thomas J Polascik
15 Contemporary External Beam Radiotherapy
Rahul Tendulkahr
Kevin Stephans
16 Surgery, Brachytherapy, or External Beam Radiation for Low and Intermediate-Risk Disease?
Jay P Ciezki
Eric A Klein
17 The Role for Radical Prostatectomy in Advanced Prostate Cancer
R. Jeffrey Karnes
Michael L Blute18 Radiation Therapy in the Management of Locally Advanced Prostate Cancer
Joseph D Mancias
Anthony L Zeitman
19 Clinical Implications of Measuring Quality-of-Life in Early Stage Prostate Cancer
Peter Chang
Mehrdad Alemozaffar
Martin G Sanda
20 Treatment Modalities of Post-Prostatectomy Incontinence: A Historical Perspective As Well As Current Therapy Options
Christina Ching
Drogo K. Montague
21 Management of Biochemical Recurrence After Localized Treatment for Prostate Cancer
Stephen B. Williams
Toni K. Choueiri
22 Management of Newly Diagnosed Metastatic Disease
C. Lance Cowey
Thomas E Hutson
23 Pitfalls of Androgen Deprivation Therapy
Alicia K Morgans
Matthew R Smith
24 Current Management of Castration-resistant Prostate Cancer (CRPC)
Jorge A Garcia
Robert Dreicer
25 Radiopharmaceuticals and Bone Metastasis
Oliver Sartor